tirzepatide and beta blockers Mounjaro: Safety and Interactions – Bolt Pharmacy Bridging the gap between GLP1-receptor

It's backwards

Tirzepatide, approved by the FDA as Mounjaro for type 2 diabetes and Zepbound for chronic weight management, primarily causes gastrointestinal side effects

Tirzepatide belongs to a class of medications called GLP-1 and GIP receptor agonists, and it follows a straightforward dosing pattern: one injection per week

As a rheumatologist with years of experience treating patients with autoimmune conditions, Ive seen firsthand the challenges that come with managing diseases like rheumatoid arthritis (RA), psoriasis, and psoriatic arthritis (PsA)

The chemical structure doesnt change based on who prepares it

Synjardy treatment includes a risk of lactic acidosis, which is a rare but serious medical emergency